[IS-013] Combination with SMYD2 Selective Inhibitor and Poly ADP Ribose Polymerase Inhibitor Has Therapeutic Potential against High-grade Serous Ovarian Carcinomas
Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate, which is posted in the Registration desk, PC Preview desk and Exhibition Hall.